OBJECTIVE. The purpose of this article is to summarize the evidence regarding the role of
FDG PET/CT in treatment response assessment and surveillance of lung cancer and to …

Purpose To assess hypo-fractionated particle beam therapy (PBT)'s efficacy relative to that
of photon stereotactic body radiotherapy (SBRT) for early stage (ES) non-small cell lung …

Background The optimal treatment of stage I non–small-cell lung carcinoma is subject to
debate. The aim of this study was to compare overall survival and oncologic outcomes of …

Introduction Many efforts have been made to detect local relapse (LR) in the follow-up after
stereotactic body radiotherapy (SBRT) for non–small-cell lung cancer (NSCLC) although …

Introduction Stereotactic body radiation therapy (SBRT) is a promising curative treatment for
early-stage NSCLC. It is unclear if survival outcomes for SBRT are influenced by a lack of …

Stereotactic body radiotherapy (SBRT) is an alternative to surgery for patients with early
stage non-small cell lung cancer (NSCLC) who are inoperable due to comorbid disease or …

This review covers the state-of-the-art imaging in therapy assessment and surveillance of
lung cancer with focus on the utility of fluorine-18 fluorodeoxyglucose positron emission …

Background Surgical resection is the most effective curative therapy for non-small cell lung
cancer (NSCLC). However, many patients are unable to tolerate resection secondary to poor …

Stereotactic body radiotherapy (SBRT) is a standard treatment for inoperable early-stage
NSCLC, with local control rates comparable to surgical series. Promising results have been …

Thoracic malignancies are among the most common cancers diagnosed both in the United
States and worldwide. The most prominent thoracic malignancy, lung cancer, is the second …